ENSI Stock Risk & Deep Value Analysis

13275

DVR Score

4.5

out of 10

Proceed with Caution

The Bottom Line on ENSI

We analyzed 13275 using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ENSI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Sep 30, 2025•Run Fresh Analysis →

📈ENSI Performance Overview3yr weekly

📊

Unlock ENSI Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

ENSI Deep Value Analysis

Ensysce Biosciences targets a massive market with a compelling vision for abuse-deterrent/overdose-protected opioids, leveraging proprietary TAAP/MPAR technologies. Clinical trials are progressing, indicating execution. However, the company is severely undercapitalized with an extremely short cash runway, necessitating continuous, highly dilutive capital raises. This unsustainable financial trajectory, without significant non-dilutive partnerships, represents a major red flag, eroding realistic 10x shareholder return potential despite technological promise and addressing a critical societal need. High regulatory hurdles and development costs amplify this risk.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

🔔

Never miss a move on ENSI

Create a free account to set price alerts and get notified on Telegram when ENSI hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for 13275 (ENSI)?

As of September 30, 2025, 13275 has a DVR Score of 4.5 out of 10, placing it in the "Proceed with Caution" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

How often is the ENSI DVR analysis updated?

Our AI-powered analysis of 13275 is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on September 30, 2025.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.